Breakthrough in Cancer Gene Therapy: Biomimetic Hybrid Vesicles Show Promise

Strategic Insights -

Researchers at the University of Genoa have made a significant breakthrough in cancer gene therapy, developing biomimetic hybrid vesicles that target colorectal cancer cells with high efficiency. This innovative approach combines the benefits of targeted drug delivery with the controlled preparation process, making it a promising strategy for treating cancer. The study, published in the Journal of Drug Delivery Science and Technology, demonstrates the potential of biomimetic vesicles in improving the treatment of colorectal cancer.

Key Takeaways:

  • The researchers developed biomimetic hybrid vesicles that mimic the cell membrane of colorectal cancer cells, allowing for targeted delivery of drugs.
  • The study used microfluidics to prepare the vesicles, which improved the production yield and increased the biocompatibility of the system.
  • The vesicles demonstrated high internalization and selectivity in vitro, with the highest value observed in homotypic internalization to parent cells.
  • The study concluded that biomimetic hybrid vesicles offer superior performance compared to artificial liposomes in targeting colorectal cancer cells.
  • The research has been peer-reviewed and published in the Journal of Drug Delivery Science and Technology.

Statistics:

  • The study used a murine cell line (CT26 cells) as the source of cell membrane for the preparation of biomimetic nanosystems.
  • The researchers used two techniques to hybridize the cell membrane with synthetic lipids: co-extrusion and hydrodynamic mixing using microfluidics.
  • The study demonstrated a 25% increase in cellular uptake of the developed systems compared to artificial liposomes.
  • The research was supported by financial supporters including FWO, NCA, Norway, Institut National du Cancer (INCA) France, ARC, France, Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK), Federal Ministry of Education & Research (BMBF).

Sources:

  • NewsRx LLC. Researchers' Work from University of Genoa Focuses on Cancer Gene Therapy (Biomimetic Hybrid Vesicles for Colorectal Cancer Targeting). Cancer Weekly. September 2, 2025; p 53.
  • Journal of Drug Delivery Science and Technology. Biomimetic Hybrid Vesicles for Colorectal Cancer Targeting. 2025;111.